MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

EKSO BIONICS HLDGS COM USD0.001(POST REV SPLIT Company Profile (NASDAQ:EKSO)

Consensus Ratings for EKSO BIONICS HLDGS COM USD0.001(POST REV SPLIT (NASDAQ:EKSO) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $21.00 (406.02% upside)

Analysts' Ratings History for EKSO BIONICS HLDGS COM USD0.001(POST REV SPLIT (NASDAQ:EKSO)
Show:
DateFirmActionRatingPrice TargetActions
4/5/2016Rodman & RenshawReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015HC WainwrightReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015Sterne Agee CRTInitiated CoverageBuy$12.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015Ladenburg ThalmannInitiated CoverageBuy$24.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for EKSO BIONICS HLDGS COM USD0.001(POST REV SPLIT (NASDAQ:EKSO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/9/2016        
3/14/2016($0.05)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015($0.04)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2015($0.04)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/17/2015($0.03)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for EKSO BIONICS HLDGS COM USD0.001(POST REV SPLIT (NASDAQ:EKSO)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for EKSO BIONICS HLDGS COM USD0.001(POST REV SPLIT (NASDAQ:EKSO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for EKSO BIONICS HLDGS COM USD0.001(POST REV SPLIT (NASDAQ:EKSO)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for EKSO BIONICS HLDGS COM USD0.001(POST REV SPLIT (NASDAQ:EKSO)
DateHeadline
06/07/16 05:00 AMEKSO Bionics Robotic Exoskeletons Gain Global Connectivity With Vodafone IoT Technology - [Marketwired] - Vodafone will be connecting the world's first and only exoskeleton that is FDA cleared for use with both stroke patients and spinal cord injuries -- the Ekso GT™ from Ekso Bionics®. Vodafone's network ...
06/03/16 10:02 AMEkso Bionics Holdings, Inc. :EKSO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016 -
06/02/16 05:27 PMEkso Bionics Announces Inaugural Open House Event - [GlobeNewswire] - RICHMOND, Calif., June 02, 2016-- Ekso Bionics Holdings, Inc., a robotic exoskeleton company, today announced that they will open their doors to the general public on the afternoon of Friday, June 10th, ...
05/04/16 03:31 PMEkso Bionics announces 1-for-7 Reverse Stock Split in preparation for Proposed Uplisting to NASDAQ - [GlobeNewswire] - RICHMOND, Calif., May 04, 2016-- Ekso Bionics Holdings, Inc., a robotic exoskeleton company, today announced that it has effected a 1- for-7 reverse split of its common stock in preparation for its planned ...
05/04/16 06:00 AMSoldierStrong to Donate Ekso GT™ Robotic Exoskeleton for Use with Stroke and Spinal Cord Injury Patients - [GlobeNewswire] - STAMFORD, Conn., May 04, 2016-- SoldierStrong, a nonprofit organization dedicated to providing advanced medical technologies to veterans, today announced that it will donate an Ekso GT™ exoskeleton to ...
04/27/16 03:03 PMEkso Bionics to Report First Quarter 2016 Financial Results on May 10, 2016 - [GlobeNewswire] - RICHMOND, Calif., April 27, 2016-- Ekso Bionics Holdings, Inc., a robotic exoskeleton company, today announced that it will release financial and business results for the first quarter 2016 after the close ...
04/20/16 06:30 AMEkso Bionics Appoints Thomas Looby as President and Chief Executive Officer - [GlobeNewswire] - RICHMOND, Calif., April 20, 2016-- Ekso Bionics Holdings, Inc., a robotic exoskeleton company, today announced that it has appointed Thomas Looby as president and chief executive officer, effective immediately. ...
04/04/16 06:00 AMEkso GT™ Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients - [GlobeNewswire] - RICHMOND, Calif., April 04, 2016-- Ekso Bionics Holdings, Inc., a robotic exoskeleton company, today announced that it has received clearance from the U.S. Food and Drug Administration to market its Ekso ...
03/21/16 12:35 PMEkso Bionics Holdings, Inc. :EKSO-US: Earnings Analysis: Q4, 2015 By the Numbers -
03/21/16 10:03 AMEkso Bionics Holdings, Inc. :EKSO-US: Earnings Analysis: 2015 By the Numbers -
03/14/16 03:05 PMEkso Bionics Reports Fourth Quarter and Year End 2015 Results - [GlobeNewswire] - RICHMOND, Calif., March 14, 2016-- Ekso Bionics Holdings, Inc., a robotic exoskeleton company, today reported financial results for the three and twelve months ended December 31, 2015.. Appointed Thomas ...
01/14/16 07:20 AMEquities Lead Investor Sentiment -- Complementary Research on Hybrid Coating Technologies, Viropro, Ekso Bionics Holdings and Hong Kong and China Gas - [Accesswire] - NEW YORK, NY / ACCESSWIRE / January 14, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Hybrid Coating ...
01/12/16 08:00 AMAttention for Bionik Labs Building with Investor Showcases for its Groundbreaking Aid for Ambulation - [Accesswire] - NEW YORK, NY / ACCESSWIRE / January 12, 2016 / Medical technology advances at different paces for different applications. Designing new tools for ailing hearts has slowed considerably in the last few decades; ...
01/11/16 06:30 AMTiming is Crucial, Upside Analysis -- Complementary Research on Ekso Bionics Holdings, ASA Gold and Precious Metals, Perceptron and Westfield Financial - [Accesswire] - NEW YORK, NY / ACCESSWIRE / January 11, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Ekso Bionics ...
01/11/16 06:00 AMEkso Bionics Announces New Clinical Trial Underway in Europe - [GlobeNewswire] - RICHMOND, Calif., Jan. 11, 2016-- Ekso Bionics Holdings, Inc., a leading global robotic exoskeleton company, announced a new randomized comparative clinical trial is currently underway in Europe. The trial ...
01/05/16 08:15 AMPoised to Profit as Robotic Exoskeletons Go Mainstream - [Accesswire] - REDONDO BEACH, CA / ACCESSWIRE / January 5, 2016 / Robotic exoskeletons have been a cornerstone of science-fiction movies, ranging from Aliens back in 1986 to Avengers: Age of Ultron earlier this year. ...
12/31/15 12:04 PMEKSO BIONICS HOLDINGS, INC. Financials -
12/29/15 06:02 AMEKSO BIONICS HOLDINGS, INC. Files SEC form 8-K, Other Events -
12/24/15 07:39 AMEKSO BIONICS HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of -
12/24/15 06:30 AMEkso Bionics Holdings Announces $15 Million Registered Direct Offering - [GlobeNewswire] - RICHMOND, Calif., Dec. 24, 2015-- Ekso Bionics Holdings, Inc., a global robotic exoskeleton company, announced today that it entered into a definitive agreement with certain healthcare focused institutional ...
12/23/15 11:52 AMEkso Bionics Holdings, Inc. Earnings Analysis: Q3, 2015 By the Numbers -
12/16/15 07:10 AMHow it All Plays Out - Analyst Review of Solarwindow, Ekso Bionics, LabStyle and Legacy Ventures - [Accesswire] - NEW YORK, NY / ACCESSWIRE / December 16, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Solarwindow ...
12/16/15 06:24 AMIndustrial Commodities and Biotechs Stand Out Among Micro Cap Stocks for 2016 - [Accesswire] - DELRAY BEACH, FL / ACCESSWIRE / December 16, 2015 / Investors and day traders alike seeking high potential returns may want to take a glance at companies vying to stay competitive in today's market through ...
12/04/15 07:31 AMEKSO BIONICS HOLDINGS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Regulation FD Disclosure -
12/04/15 06:30 AMEkso Bionics(R) Acquires Gravity Balancing Arm Technology From Equipois, LLC - [GlobeNewswire] - RICHMOND, Calif. -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a leading global robotic exoskeleton company, announced today it acquired the gravity balancing arm technologies of Equipois, LLC, including ...
11/24/15 07:10 AMEquity Market Movement at a Glance - Research on Northwest Biotherapeutics, Elite Pharmaceuticals, Ekso Bionics Holdings, and Medical Marijuana - [Accesswire] - NEW YORK, NY / ACCESSWIRE / November 24, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Northwest ...
11/18/15 01:46 PMRobotics in the Medical World: A Booming Industry Where Technology will Excel - [Accesswire] - NEW YORK, NY / ACCESSWIRE / November 18, 2015 / Once existing only in the imaginations of science fiction writers, robots - mechanical devices meant to imitate human movement and function, became a reality ...
11/16/15 07:00 AMThe Price Data Tells the Story – Research on Northwest Biotherapeutics, Elite Pharmaceuticals, Barrett Business Services and Ekso Bionics Holdings - [Accesswire] - NEW YORK, NY ACCESSWIRE / November 16, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Northwest Biotherapeutics ...
11/12/15 06:00 AMEkso Bionics(R) to Establish Headquarters in Freiburg, Germany; Strengthens European Expansion Efforts - [GlobeNewswire] - RICHMOND, Calif. -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a leading global robotic exoskeleton company, announced today that it has established a new regional headquarters, based in Freiburg, Germany, ...
11/09/15 08:14 AMEKSO BIONICS HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report -
11/09/15 06:45 AMEquities Lead Investor Sentiment - Research on Elite Pharmaceuticals, Medical Marijuana, Ekso Bionics Holdings and Pharmacyte Biotech - [Accesswire] - NEW YORK, NY / ACCESSWIRE / November 9, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Elite Pharmaceuticals ...
About EKSO BIONICS HLDGS COM USD0.001(POST REV SPLIT

EKSO BIONICS HLDGS COM USD0.001(POST REV SPLIT logo

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: EKSO
  • CUSIP:
Key Metrics:
  • Previous Close: $4.35
  • 50 Day Moving Average: $5.58
  • 200 Day Moving Average: $6.24
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $67.16M
  • Current Quarter EPS Consensus Estimate: $-1.48 EPS
Additional Links:
EKSO BIONICS HLDGS COM USD0.001(POST REV SPLIT (NASDAQ:EKSO) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha